Comparison of Outcome of Open Appendectomy With and Without Transversus Abdominis Plane (TAP) Block
Launched by UNIVERSITY OF HEALTH SCIENCES LAHORE · Apr 16, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to manage pain for patients undergoing an open appendectomy, which is surgery to remove the appendix. One group of patients will receive a special pain relief technique called a Transversus Abdominis Plane (TAP) block, which numbs the abdominal area to help reduce pain after surgery. The other group will have the same surgery but will not receive this TAP block. The goal is to see if using the TAP block can lead to less pain after surgery, shorter hospital stays, fewer complications like nausea and vomiting, and greater overall satisfaction from the patients.
To participate in this study, individuals must be adults aged 18 to 65 who are diagnosed with appendicitis and are fit for general anesthesia. They should have specific symptoms such as pain in the lower right abdomen and possibly fever. However, those with certain conditions, like severe liver disease or who are pregnant, cannot take part. If you do join the trial, you’ll be randomly placed into one of the two groups, and the researchers will follow your recovery to gather important information that could improve pain management for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 to 65 years.
- • Both male and female patients.
- • Patients fit for general anesthesia.
- • Clinical findings of appendicitis.
- • Lower right quadrant or periumbilical pain radiating to the right lower quadrant, with nausea and/or vomiting.
- • Fever \>38°C.
- • Tenderness with Alvarado score \>7.
- Exclusion Criteria:
- • Duration of symptoms \>5 days.
- • Absence of clinical findings of appendicitis.
- • Palpable mass on physical examination suspected for appendiceal abscess.
- • History of cirrhosis or hematological disorders.
- • Allergic to or contraindicated for general anesthesia.
- • Pregnancy.
- • Patients who do not consent to participate.
About University Of Health Sciences Lahore
The University of Health Sciences Lahore (UHS Lahore) is a premier educational and research institution dedicated to advancing healthcare through innovative clinical research and education. With a strong emphasis on interdisciplinary collaboration, UHS Lahore aims to enhance the quality of health services in Pakistan and beyond. The university actively sponsors clinical trials that contribute to the understanding and treatment of various medical conditions, fostering an environment of scientific inquiry and ethical research practices. By integrating cutting-edge methodologies and robust training programs, UHS Lahore plays a pivotal role in shaping the future of healthcare professionals and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported